A detailed history of New York State Teachers Retirement System transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Teachers Retirement System holds 100,427 shares of REGN stock, worth $74.1 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
100,427
Previous 99,520 0.91%
Holding current value
$74.1 Million
Previous $105 Million 0.93%
% of portfolio
0.22%
Previous 0.22%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$1024.09 - $1201.76 $928,849 - $1.09 Million
907 Added 0.91%
100,427 $106 Million
Q2 2024

Jul 24, 2024

SELL
$883.2 - $1071.19 $3.23 Million - $3.92 Million
-3,656 Reduced 3.54%
99,520 $105 Million
Q1 2024

Apr 25, 2024

SELL
$902.69 - $993.35 $3.4 Million - $3.74 Million
-3,762 Reduced 3.52%
103,176 $99.3 Million
Q4 2023

Jan 24, 2024

SELL
$775.18 - $881.7 $2.35 Million - $2.67 Million
-3,029 Reduced 2.75%
106,938 $93.9 Million
Q3 2023

Oct 25, 2023

SELL
$692.45 - $844.37 $3.88 Million - $4.73 Million
-5,601 Reduced 4.85%
109,967 $90.5 Million
Q2 2023

Jul 27, 2023

SELL
$700.03 - $830.35 $3.44 Million - $4.08 Million
-4,919 Reduced 4.08%
115,568 $83 Million
Q1 2023

Apr 27, 2023

SELL
$680.49 - $826.97 $1.89 Million - $2.3 Million
-2,783 Reduced 2.26%
120,487 $99 Million
Q4 2022

Jan 27, 2023

SELL
$705.89 - $766.39 $2.39 Million - $2.59 Million
-3,382 Reduced 2.67%
123,270 $88.9 Million
Q3 2022

Oct 28, 2022

SELL
$573.97 - $724.32 $319,127 - $402,721
-556 Reduced 0.44%
126,652 $87.2 Million
Q2 2022

Aug 01, 2022

BUY
$548.35 - $738.84 $48,254 - $65,017
88 Added 0.07%
127,208 $75.2 Million
Q1 2022

Apr 27, 2022

BUY
$595.12 - $698.43 $700,456 - $822,052
1,177 Added 0.93%
127,120 $88.8 Million
Q4 2021

Jan 24, 2022

SELL
$543.48 - $670.97 $216,305 - $267,046
-398 Reduced 0.32%
125,943 $79.5 Million
Q3 2021

Oct 25, 2021

SELL
$574.03 - $680.96 $1.38 Million - $1.63 Million
-2,401 Reduced 1.86%
126,341 $76.5 Million
Q2 2021

Jul 21, 2021

SELL
$472.8 - $558.54 $2.19 Million - $2.59 Million
-4,637 Reduced 3.48%
128,742 $71.9 Million
Q1 2021

Apr 22, 2021

BUY
$446.73 - $548.2 $33,504 - $41,115
75 Added 0.06%
133,379 $63.1 Million
Q4 2020

Jan 25, 2021

BUY
$478.3 - $607.98 $535,217 - $680,329
1,119 Added 0.85%
133,304 $64.4 Million
Q3 2020

Nov 06, 2020

BUY
$544.75 - $658.21 $1.54 Million - $1.86 Million
2,828 Added 2.19%
132,185 $0
Q2 2020

Jul 21, 2020

BUY
$493.32 - $643.92 $11.1 Million - $14.5 Million
22,566 Added 21.13%
129,357 $80.7 Million
Q1 2020

Apr 29, 2020

SELL
$336.18 - $494.43 $773,214 - $1.14 Million
-2,300 Reduced 2.11%
106,791 $52.1 Million
Q4 2019

Jan 24, 2020

BUY
$274.13 - $376.51 $342,388 - $470,260
1,249 Added 1.16%
109,091 $41 Million
Q3 2019

Oct 24, 2019

SELL
$273.46 - $318.39 $361,514 - $420,911
-1,322 Reduced 1.21%
107,842 $29.9 Million
Q2 2019

Jul 18, 2019

SELL
$299.6 - $414.82 $1.1 Million - $1.52 Million
-3,667 Reduced 3.25%
109,164 $34.2 Million
Q1 2019

May 07, 2019

BUY
$372.08 - $439.57 $1.54 Million - $1.82 Million
4,147 Added 3.82%
112,831 $46.3 Million
Q4 2018

Jan 28, 2019

SELL
$335.82 - $403.04 $1.41 Million - $1.69 Million
-4,192 Reduced 3.71%
108,684 $40.6 Million
Q3 2018

Nov 02, 2018

SELL
$351.14 - $408.51 $1.18 Million - $1.37 Million
-3,361 Reduced 2.89%
112,876 $45.6 Million
Q2 2018

Aug 01, 2018

SELL
$284.6 - $344.99 $1.12 Million - $1.36 Million
-3,930 Reduced 3.27%
116,237 $40.1 Million
Q1 2018

May 01, 2018

SELL
$315.82 - $393.78 $217,284 - $270,920
-688 Reduced 0.57%
120,167 $41.4 Million
Q4 2017

Feb 12, 2018

BUY
$358.63 - $469.95 $4,662 - $6,109
13 Added 0.01%
120,855 $45.4 Million
Q3 2017

Oct 30, 2017

SELL
$431.38 - $504.0 $198,866 - $232,344
-461 Reduced 0.38%
120,842 $54 Million
Q2 2017

Aug 11, 2017

BUY
N/A
121,303
121,303 $59.6 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track New York State Teachers Retirement System Portfolio

Follow New York State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.